SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001178913-24-000086
Filing Date
2024-01-08
Accepted
2024-01-08 06:35:48
Documents
1
Group Members
I.B.F MANAGEMENT LTD.ISRAEL BIOTECH FUND GP PARTNERS II, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A zk2430751.htm SC 13G/A 66767
  Complete submission text file 0001178913-24-000086.txt   68375
Mailing Address 42 HAYARKON STREET YAVNE L3 8122745
Business Address 42 HAYARKON STREET YAVNE L3 8122745 97289324010
MediWound Ltd. (Subject) CIK: 0001593984 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88069 | Film No.: 24518234
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)

Mailing Address 4 OPPENHEIMER ST. REHOVOT L3 7670104
Business Address 4 OPPENHEIMER ST. REHOVOT L3 7670104 972-72-251-4175
Israel Biotech Fund II, L.P. (Filed by) CIK: 0001782947 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A